Common Shares, No Par Value
- Symbol
- BLCO
- Exchange
- NYSE
- Classification
- COMMON
Current Report · Items 5.02 · 8-K
Bausch + Lomb Corporation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 28, 2026, Nathalie Bernier notified Bausch + Lomb Corporation (the “Company”) of her decision to resign from the Board of Directors of the Company (the “Board”) and from the Science and Technology Committee of the Board, effective a…
Company context
Our mission is simple - we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
Current securities
Recent company filings
Registered securities in this filing
Bausch & Lomb Corp · 8-K · Filed 2026-10-28
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 28, 2026, Nathalie Bernier notified Bausch + Lomb Corporation (the “Company”) of her decision to resign from the Board of Directors of the Company (the “Board”) and from the Science and Technology Committee of the Board, effective at the close of business. In connection with Ms. Bernier’s resignation and entry into a general mutual release of certain claims, the Company has agreed to pay Ms. Bernier prorated cash compensation for her service and to accelerate the vesting, in full, of the outstanding and unvested restricted share unit awards received by Ms. Bernier as part of her 2026 annual grant. The Board does not currently intend to fill the board vacancy created by Ms. Bernier’s resignation.
Ms. Bernier’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.